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Abstract: Artificial Intelligence (AI) imaging diagnosis is developing, making enormous steps
forward in medical fields. Regarding diabetic nephropathy (DN), medical doctors diagnose them with
clinical course, clinical laboratory data and renal pathology, mainly evaluate with light microscopy
images rather than immunofluorescent images because there are no characteristic findings in
immunofluorescent images for DN diagnosis. Here, we examined the possibility of whether AI
could diagnose DN from immunofluorescent images. We collected renal immunofluorescent images
from 885 renal biopsy patients in our hospital, and we created a dataset that contains six types of
immunofluorescent images of IgG, IgA, IgM, C3, C1q and Fibrinogen for each patient. Using the
dataset, 39 programs worked without errors (Area under the curve (AUC): 0.93). Five programs
diagnosed DN completely with immunofluorescent images (AUC: 1.00). By analyzing with Local
interpretable model-agnostic explanations (Lime), the AI focused on the peripheral lesion of DN
glomeruli. On the other hand, the nephrologist diagnostic ratio (AUC: 0.75833) was slightly inferior
to AI diagnosis. These findings suggest that DN could be diagnosed only by immunofluorescent
images by deep learning. AI could diagnose DN and identify classified unknown parts with the
immunofluorescent images that nephrologists usually do not use for DN diagnosis.
Keywords: immunofluorescent image; renal pathology; artificial intelligence; deep learning;
diabetic nephropathy
1. Introduction
Lifestyle-related diseases are a big issue for worldwide health. Diabetes mellitus (DM) and
chronic kidney diseases are believed to be lifestyle-related diseases. When DM worsens and progresses,
diabetic nephropathy (DN) is caused as a microvascular complication. The diagnosis of DN is based on a
long history of DM, the presence of other microangiopathies such as diabetic retinopathy and/or diabetic
neuropathy (Supplementary Figure S1). Sometimes, differential diagnosis is needed for DM patients
if urinary occult blood is clearly observed or a rapid renal function deterioration is demonstrated.
In that case, a renal biopsy may be performed to distinguish other glomerular diseases on the view of
renal pathology. At the point of renal biopsy evaluation for DN, renal immunofluorescent staining
images are considered unimportant because there are few specific features of renal immunofluorescent
images in DN. DN is diagnosed typically with nodular lesions, exudative lesions and diffuse lesions
in light microscopy images (Supplementary Figure S1). Immunofluorescent images are sensitive
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in demonstrating the immune complex deposition in the kidney. Immunofluorescence images of
DN reveal no specific immune complex deposition because DN is not involved in the immune
mechanism pathophysiologically. Therefore, immunofluorescent image analysis for DN has been
relatively neglected.
On the other hand, it is expected that artificial intelligence (AI) will be applied to medical diagnosis
and treatment [1]. AI is believed to be excellent for image recognition. The application of AI has been
studied in various fields such as radiographic imaging [2], cancer invasion [3], drug discovery [4]
and ophthalmology [5]. In nephrology, various reports are expected, such as the prediction of acute
kidney injury from a patient’s big data [6], segmentation of renal tissue images [7] and renal function
prediction from renal echo images [8]. However, AI performs the diagnosis or treatment by using
the data that human doctors use. There are few reports on whether AI could diagnose or predict the
diseases using the data that human doctors do not employ.
Here, we examined whether DN can be diagnosed by AI based on immunofluorescent images that
are rarely used in clinical practice by human doctors. AI excels in the pattern recognition of images and
data, and may be able to extract and discriminate features that are barely discernible by human eyes.
2. Materials and Methods
2.1. Patients Information
This study was approved by the committee of Okayama University at 2 August 2019 (approved #:
ken1908-008). This study is a retrospective observational study. As for informed consent, the contents
of the research are posted on our department homepage and in the hospital, and public informed
consent was provided. Kidney samples consisted of needle biopsy samples from patients that
were hospitalized to undergo the examination of renal biopsy in Okayama University hospital
from January 2008 to May 2018. The number of renal biopsy patients is 885 from 2012–2018 in the
Okayama University hospital. During the 2012–2018 period, the number of DN renal biopsy patients
was 31 in the Okayama University hospital. For comparison, 130 non-DN patients’ images were
collected in 2018. Among them, we excluded 78 patients because of renal transplantation episode
biopsy, complicated multiple nephropathy and uncertain diagnosis. The diagnosis of remaining
52 non-DN patients was shown in Supplementary Figure S2. Almost a quarter of them are IgA
nephropathy patients (Supplementary Table S1). The diagnosis of the renal disease was decided by
the nephrologists with the discussion in conference by using the patient’s medical history, physical
information, clinical examination information and pathological findings including immunofluorescent
images, light microscopy images and electron microscopy images.
2.2. Renal Immunofluorescent Images
The kidney samples were obtained by renal biopsy from the patients administrated in Okayama
University Hospital. We made frozen sections from renal biopsy samples, and cut at 4 um in a cryostat.
We stained the frozen sections by fluorescein isothiocyanate (FITC)-conjugated antibodies in a moist
chamber for 1 h. FITC-conjugated goat anti-human IgA, IgM, C3, C1q and fibrinogen were purchased
from MP biomedicals, LLC, and FITC-conjugated goat anti-human IgG was purchased from Medical
and Biological Laboratories Co., LTD. The images were obtained by fluorescence microscopes (Olympus,
Japan). We collected only glomerular immunofluorescent images from each section. To analyze each
glomerular image by deep learning, we aligned each size of glomerular images for comparison.
2.3. Data Preprocessing
The image data were obtained as JPEGs or Tiff files. We changed the resolution of the files from
2776 × 2074 pixel to 256 × 256 pixels. After the conversion, we converted the JPEG file into a PNG file
for analysis.
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2.4. Deep Learning
Python was used as the programming language, and the environment was Microsoft’s visual studio
code and neural network console (Sony Network Communications Inc., Tokyo, Japan.). The input was
six types of renal immunofluorescent images of IgG, IgA, IgM, C3, C1q, and fibrinogen converted as
previously described. The renal pathological images are classified into training images and test images
at a ratio of 8:2. The test images are shown in Supplementary Figure S3. We performed supervised
training for deep learning.
2.5. Statistical Analysis
Statistical analysis was performed by JMP (SAS Institute Inc. version 11.0.0 for Windows software,
Tokyo, Japan). Statistical significance was defined by one-way analysis of variance (ANOVA) with
Student’s T-test. Data are shown as the mean ± SE. Significance was defined as p < 0.05. In addition,
to determine the cut-off value of the DN diagnosis, a receiver operating characteristic (ROC) curve was
constructed using statistical analysis software JMP.
3. Results
3.1. Overview of Computer Schema of Deep Learning
An overview of the computational schema is shown (Figure 1). We input six kinds of
immunofluorescent images, IgG, IgA, IgM, C3, C1q and Fibrinogen. Each image resolution is
256 × 256 pixel. Each image was analyzed, and six types of data were integrated, analyzed again
and connected to the output. We used the software Neural Network Console provided by Sony Inc.
This software automatically adds or deletes some layers to adjust parameters, obtaining an optimum
result. Using this software, we created 419 different types of programs in this study. We evaluated
them with a learning curve for each program. Some programs did not work well, and we harvested
some better programs for this study.
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3.2. AI Could Diagnose DN from Immunofluorescent Images
A total of 419 programs were trained using the immunofluorescent images obtained in our
hospital (representative: Supplementary Figure S4, a: schema of program, b: learning curve, c: result
of diagnosis). Their programs ranged in accuracy from 30% to as high as 100%. The total area under
the curve (AUC) of the diagnostic rate of all the created programs was 0.71807, R2 0.2213, p < 0.0001
(Figure 2a,b). In addition, among the obtained programs, we analyzed the 39 programs where the
accuracy ratio was 60% or more. In these extracted programs, the accuracy rate was 83.28 ± 11.64%,
the precision rate was 80.56 ± 21.83%, and the recall rate was 79.87 ± 15.65%, and the AUC was 0.92914,
R2 0.4586, p < 0.0001 (Figure 2c,d). Six programs showed 100% accuracy, precision, and recall, and the
AUC was 1.000, R2 1.000, p < 0.0001 (Figure 2e,f). This indicates that AI could automatically extract
features from limited image information, and that the judgment is reproduced at high rates even in
test data.
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AUC 0.71807, p < .0001, R2 0.2213. (c,d) For 39 programs with accuracy above 60% average, (c) Logistic
finding curve; DN: 0, non-DN: 1, (d) ROC curve; AUC 0.92914, p < 0.0001, R2 0.4586. (e,f) For six
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3.3. The Differences of the Diagnosis among DN Immunofluorescent Images
Next, the DN images used in the test dataset were analyzed in the point of accuracy. We used test
image data, which consisted of, representatively, six DN patients’ images (Figure 3). We compared the
accuracy with four types programs, the complete diagnosis program (CP: Supplementary Figures S5
and S6a,b), false negative program (FN: Supplementary Figures S7 and S8a,b), false positive program
(FP: Supplementary Figures S9 and S10a,b), and average accuracy program (AV: Supplementary
Figures S11 and S12a,b). Regarding each accuracy, patient #1 and patient #4 showed a lower accuracy
ratio compared to other DN patients. On the FN program, patient #1 and #4 were not diagnosed as
DN. On the other hand, in terms of picking up DN, the FP program could pick up all DN images.
However, the FP program diagnosed interstitial nephritis and antineutrophil cytoplasmic antibody
(ANCA)-related nephritis as DN (Supplementary Figure S10b). In the AV program, patient #1 did not
diagnose as DN, and other DN patients diagnosed as DN slightly above the diagnosis line. These results
suggest that AI could diagnose DN the same as a human could.
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3.4. Lime Analysis
Next, to determine the characteristic findings in glomerular changes on DN, we examined
which parts of image areas were the main focus under AI diagnosis by using the local interpretable
model-agnostic explanations (Lime) analysis. The Lime analysis could show the part where AI mainly
makes a decision. We chose representative images of patient #1 (Figure 3). The CP program focused
on a part of the central site and the periphery (Figure 4 CP, Supplementary Figure S13), In addition,
another CP program focused on the periphery (Supplementary Figure S14). These results suggest that
characteristic findings may be located at the periphery for glomeruli of DN. In programs that produce
false negatives (FN), judgments were often made only at the margins (Figure 4 FN). Conversely, even in
programs that produce false positives (FP), judgments were based only on the margins (Figure 4 FP).
In programs with both false positives and false negatives (AV), judgements were made at the center
and margins (Figure 4 AV). These results suggest that, as a characteristic finding, judgment was made
mainly on the change of the snare, and the judgment was compared with the central part.
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3.5. The Diagnostic Comparison between Nephrologist and AI
To compare the differences between humans and AI, we provided the diagnosis test to
nephrologists, using the same test data. Among 39 previously described programs that showed
the accuracy above 60%, the diagnosis rate of the test images by the AI was 83.28 ± 11.64% for the
accuracy ratio, 80.56 ± 21.83% for the precision ratio and 79.87 ± 15.65% for the recall ratio (Figure 2c,d).
On the other hand, the diagnosis rate of the test images by the nephrologist was 67.50 ± 6.12% for
the correct answer rate, 62.62 ± 3.85% for the precision rate, and 67.26 ± 9.96% for the recall rate
(Figure 5a,b). These results suggest that AI could diagnose the DN in a superior way to nephrologists.
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4. Discussion
The purpose of this study is to examine whether AI can automatically extract features from images
that doctors do not consider important in diagnosis by deep learning, and whether AI could make
a diagnosis.
DN is usually diagnosed with reference to the long-term history of diabetes and the presence of
microangiopathic complications such as diabetic retinopathy. When it is necessary to differentiate
from other renal diseases in DM patients, because of the preference of atypical features in DN
such as hematuria, sudden onset of proteinuria, and a change in renal function, a renal biopsy is
performed and the patients are diagnosed from renal pathology. In DN, characteristic lesions such
as diffuse lesions, exudative lesions, and nodular lesions are observed in light microscopy, however,
the immunofluorescent images are not used because there are no significant parts. AI can automatically
extract and classify features from the immunofluorescent images. From the Lime analysis, AI pointed
out the changes in the peripheral vessel loop. At the peripheral vessels loop, we could observe the
changes of vessel loop thickening and/or wrinkling in the light microscopy. However, the changes
were very subtle in immunofluorescent images, thus we could not observe any significance compared
to other glomeruli with nephritis using human eyes.
However, in the analysis of AI, there are still many unclear points about the judgment during the
process, and this is said to be the so-called AI black box problem. In the future, we hope that a method
will be created that allows humans to understand AI decisions. In this study, we did not examine the
difference in the diagnosis rate when using light microscopy images. AI may develop to be better
for diagnosis with light microscopic images because there are significant diagnostic points in light
microscopic images.
As a study limitation, AI diagnosis is performed only from immunofluorescent images that were
small datasets from limited patient images. In order to validate them, verification will be necessary by
adding data from other hospitals. In addition, human doctors diagnose comprehensively with clinical
course, clinical findings and clinical images, such as light microscope images and electron microscope
images. To compare the differences between human and AI, further examination is needed.
This study showed that AI extracts characteristic findings even from data that people do not
normally use. This indicates that when a medical doctor makes a clinical diagnosis, AI can independently
extract the findings that human doctors find difficult to notice. This study suggested that AI is not a
threat to clinicians, but a partner that points out the difficult points which humans do not notice.
Supplementary Materials: The following are available online at http://www.mdpi.com/2075-4418/10/7/466/s1.
Supplemental Figure S1; The diagnosis method for diabetes mellites nephropathy (DN). Supplementary Figure S2;
Enrolment. All patients underwent renal biopsy in Okayama University Hospital. Supplementary Table S1;
compared other nephropathy and patient number. Supplementary Figure S3a-c; (a) Test data set for DN.
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(b) Test data set for non DN. A: C3 nephropathy, B: FGS (focal segmental glomerular sclerosis), C: MPGN
(membranoproliferative glomerulonephritis), D: TBM (thin basement membrane disease) E: MCNS (micro change
nephrotic syndrome), F: interstitial nephritis, G: ANCA (antineutrophil cytoplasmic antibody) related disease.
(c) Test data set for non DN. H: MN (Membranous nephropathy), I: IgA-N (IgA nephritis), J: IgA-N. Supplementary
Figure S4; Representative CNN data. (a) schema of CNN; (b) learning curve; (c) evaluation data (y = 0: DN, y = 1:
non DN, y’ = 0: estimated DN, y’ = 1: estimated non DN). Supplementary Figure S5; Representative completely
diagnosis (CP) CNN data. (a) schema of CNN; (b) learning curve; (c) evaluation data (y = 0: DN, y = 1: non DN,
y’ = 0: estimated DN, y’ = 1: estimated non DN). Supplementary Figure S6a, b; (a) representative completely
(CP) DN diagnosis ratio for DN patients’ images. (b) representative completely (CP) DN diagnosis ratio for
non DN patients’ images. Supplementary Figure S7; Representative false negative diagnosis (FN) CNN data.
(a) schema of CNN; (b) learning curve; (c) evaluation data (y = 0: DN, y = 1: non DN, y’ = 0: estimated DN,
y’ = 1: estimated non DN). Supplementary Figure S8a, b; (a) representative false negative (FN) DN diagnosis
ratio for DN patients’ images. (b) representative false negative (FN) DN diagnosis ratio for non DN patients’
images. Supplementary Figure S9; Representative false positive diagnosis (FP) CNN data. (a) schema of CNN;
(b) learning curve; (c) evaluation data (y = 0: DN, y = 1: non DN, y’ = 0: estimated DN, y’ = 1: estimated non
DN). Supplementary Figure S10a, b; (a) representative false negative (FN) DN diagnosis ratio for DN patients’
images. (b) representative false negative (FN) DN diagnosis ratio for non DN patients’ images. Supplementary
Figure S11; representative average diagnosis (AV) CNN data; (a) schema of CNN; (c) learning curve; (c) evaluation
data (y = 0: DN, y = 1: non DN, y’ = 0: estimated DN, y’ = 1: estimated non DN). Supplementary Figure S12a,b;
(a) representative average (AV) DN diagnosis ratio for DN patients’ images. (b) representative average (AV) DN
diagnosis ratio for non DN patients’ images. Supplementary Figure S13; Lime analysis for patient #1 images with
completely diagnosis program #1. Supplementary Figure S14; Lime analysis for patient #1 images with another
completely diagnosis program #6.
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